JPM
JPMorgan Chase & Co.
JPM's outlook is improving, though it still trails on the overall score.
PDLB
Ponce Financial Group, Inc.
PDLB has the edge over JPM overall, supported by stronger valuation and stronger modeled upside.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
PDLB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
PDLB's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like PDLB.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
PDLB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $22.20 | — |
| Current | 12x | $22.20 | — |
| Cheap | 15x | $27.86 | +26% |
| Fair | 22x | $42.18 | +90% |
| Expensive | 38x | $72.93 | +229% |
Historical ranges are pointers, not guarantees.
PDLB has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over PDLB on the outlook, with more favorable profitability expectations.
PDLB Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for PDLB, with profitability holding steady.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
PDLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.99 | +4.7% |
| Q3 2026 | $1.90 | +116% |
| Q2 2026 | $1.41 | +99% |
| Q1 2026 | $1.31 | +118% |
| Q4 2025 | $1.20 | +161% |
| Q3 2025 | $0.88 | +138% |
| Q2 2025 | $0.71 | +82% |
| Q1 2025 | $0.60 | +140% |
| Q4 2024 | $0.46 | +207% |
PDLB has the edge over JPM on earnings, with stronger typical year-over-year growth.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over PDLB on profitability, with a higher operating margin.
PDLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $34.8M | +30% |
| Q2 2026 | $31.6M | +19% |
| Q1 2026 | $30.3M | +23% |
| Q4 2025 | $31.4M | +38% |
| Q3 2025 | $26.7M | +33% |
| Q2 2025 | $26.5M | +31% |
| Q1 2025 | $24.6M | +20% |
| Q4 2024 | $22.8M | +24% |
PDLB has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | +2.8 points |
| Q2 2026 | 36% | +5.6 points |
| Q1 2026 | 38% | +5.1 points |
| Q4 2025 | 44% | +24 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 30% | +8.4 points |
| Q1 2025 | 32% | +14 points |
| Q4 2024 | 20% | +14 points |
PDLB's operating margin was 36% last quarter, up 2.8 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
PDLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.4M | +1603% |
| Q2 2026 | $8M | +36% |
| Q1 2026 | $13.8M | +7% |
| Q4 2025 | $35M | +56% |
| Q3 2025 | $786K | +$15.7M |
| Q2 2025 | $5.9M | +$8.5M |
| Q1 2025 | $12.9M | +$13.2M |
| Q4 2024 | $22.4M | -30% |
PDLB has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over PDLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
PDLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +142K shares |
| 1 year | +2.2% | +515K shares |
| 3 years | +5.8% | +1.3M shares |
PDLB has 24M diluted shares, up 2.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | $5.8M |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over PDLB on leverage, with a lower net debt burden relative to earnings.
PDLB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 10.5x | High |
| Q2 2026 | 9.6x | High |
| Q1 2026 | 9.7x | High |
| Q4 2025 | 10.9x | High |
| Q3 2025 | 11.0x | High |
| Q2 2025 | 14.4x | High |
| Q1 2025 | 15.5x | High |
| Q4 2024 | 22.3x | High |
PDLB's net debt is about 11 years of its operating earnings (EBITDA), down from 11 years a year ago. Net leverage isn't a meaningful measure for financial services companies like PDLB.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
PDLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.4 | Overbought |
| Stochastic | 76.7 | Neutral |
PDLB's weekly RSI is 70 (overbought) and its Stochastic is 77 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
PDLB PE vs Financial Services Sector
| Metric | PDLB | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 10% below |
| PE % | 1 | 63 | 62 pts below |
PDLB has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
PDLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.0 | 5.8% above |
| 20 week MA | $20.6 | 7.8% above |
| 50 week MA | $18.6 | 19% above |
| 100 week MA | $16.1 | 38% above |
| 200 week MA | $12.7 | 75% above |
PDLB has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
PDLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.8 | $10.4 | -30% |
| 2021 | $10.4 | $14.7 | +42% |
| 2022 | $14.7 | $9.51 | -35% |
| 2023 | $9.51 | $9.76 | +2.6% |
| 2024 | $9.76 | $12.8 | +31% |
| 2025 | $12.8 | $16.8 | +32% |
| 2026 YTD | $16.8 | $22.2 | +32% |
PDLB has the edge over JPM on returns for 2026, with the stronger performance.